On October 21, 2024 Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), reported that company executives will be participating in the Jefferies London Healthcare Conference, which is taking place November 19-21 at the Waldorf Hilton London (Press release, ImmunityBio, OCT 21, 2024, View Sourcenews-releases/news-release-details/immunitybio-participate-jefferies-london-healthcare-conference-0" target="_blank" title="View Sourcenews-releases/news-release-details/immunitybio-participate-jefferies-london-healthcare-conference-0" rel="nofollow">View Source [SID1234647284]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the presentation can be found below.

Jefferies London Healthcare Conference

Date:

Tuesday, November 19, 2024

Time:

2:30 PM GT

Format:

Fireside chat with ImmunityBio company executives

A replay of the recorded fireside presentation will be available through the Events and Presentations section of the ImmunityBio website at View Source for 90 days.